ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,373Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 1571

$537K Total Retail Price of All Prescriptions

Rank: 200 out of 1571

444 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 636 612 S3 1 3
LEVOTHYROXINE SODIUM 431 412 2 6
SIMVASTATIN 257 254 3 1
LOSARTAN POTASSIUM 239 238 4 17
FENTANYL 190 190 S2 5 132
WARFARIN SODIUM 186 185 6 14
OMEPRAZOLE 175 174 7 4
FUROSEMIDE 172 162 8 7
AMLODIPINE BESYLATE 165 158 9 2
POTASSIUM CHLORIDE 150 140 10 27
METFORMIN HCL 144 139 11 9
METOPROLOL TARTRATE 142 141 12 13
LISINOPRIL 129 129 13 5
AZITHROMYCIN 111 102 14 58
FLUTICASONE PROPIONATE 109 101 15 41
CYMBALTA 104 104 16 68
TAMSULOSIN HCL 97 96 17 11
PREDNISONE 95 92 18 34
FAMOTIDINE 91 90 19 54
DIOVAN 87 84 20 19
DIGOXIN 86 85 21 35
CIPROFLOXACIN HCL 85 77 22 38
SYNTHROID 82 81 23 59
ENALAPRIL MALEATE 81 81 24 81
DONEPEZIL HCL 81 77 24 24
MELOXICAM 77 77 26 49
PANTOPRAZOLE SODIUM 76 75 27 23
ATENOLOL 72 62 28 15
ATORVASTATIN CALCIUM 71 69 29 8
ZOLPIDEM TARTRATE 67 58 30 20
TERAZOSIN HCL 66 54 31 137
HYDROCHLOROTHIAZIDE 63 62 32 18
METOPROLOL SUCCINATE 62 61 33 16
CITALOPRAM HBR 62 61 33 66
LEVOFLOXACIN 61 58 35 79
DILTIAZEM 24HR CD 56 55 36 172
ALENDRONATE SODIUM 56 56 36 22
GABAPENTIN 55 55 38 12
LOVASTATIN 51 51 39 33
CELEBREX 50 42 40 71
MIRTAZAPINE 50 50 40 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.